Skip to content

CHARLOTTE THEUNISSEN

Active Risk: not assessed
Private limited companyfounded 2012active for 14 yearsKiezelweg 428, 3620 Lanaken, BelgiumKBO/BCE: BE 0847.201.166
Summary

CHARLOTTE THEUNISSEN has a registered holding activity and consists mainly of financial fixed assets. The bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €724,645 and a net result of €77,355. Equity has been growing by about 15% per year since 2018. Its solvency ranks better than 86% of 12,775 sector peers (NACE 47, financial year 2025). The company has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals.

Overview

Official details

Source: KBO
Status
Active since 06-07-2012 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730and 1 other
Establishment unit
2.210.976.428 3620 Lanaken, since 06-07-2012
Financial year end
31 December
Peppol
Reachable since 09-12-2025

Board and ownership

Board

Financial position

Holding: outside the score modelBankruptcy probability: sector outside the model
Annual accounts 2025
Gross margin
€120,675
▼ 17.6%
Turnover
≈ €560,000
estimated
Profit
€77,355
▼ 18.0%
Equity
€724,645
▲ 12.0%
Total assets
€962,662
▼ 0.9%
  • 2025 accounts filed 3 days after the deadline
Signalsraises risk2025 accounts filed 3 days lateShow the evidence

Checked score

Outside the general model
Holding: general score not applicable
The company has a registered holding activity. Financial fixed assets make up more than half of its assets. The general model for operating companies does not fit such a balance sheet, so there is no score and no financial strength.
Bankruptcy probability within 12 months

The company is a financial institution: a bank, insurer or financial holding. Its balance sheet works differently from that of a trading or manufacturing company. A bankruptcy probability from the general model would mislead here.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

1 signal.
raises risk
raises risk · 2025 accounts filed 3 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-08-2026, 3 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
3 days late
2024
7 days early
2023
19 days early
2022
28 days late
2021
17 days late
2020
20 days late
2019
33 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 11 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 3 August (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher solvency than 85% of companies in retail tradesector median 36.6% · 12,775 companies 75.3% View
  • Positive: 8 profitable years in a rowprofit 2025: €77,355 8 years View

Recent changes

  1. · Gazette deed Reappointment: THEUNISSEN Charlotte (director)
  2. · Gazette deed Incorporation
All 15 events

Comparable companies

These companies have the same main activity as CHARLOTTE THEUNISSEN: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €825,000 and €1.1m, founded between 2010 and 2014.

CompanyTotal assetsGross margin
CHARLOTTE THEUNISSEN Lanaken€1.0m€0.1m
D'HAEN PHARMA Zottegem€1.0m€0.1m
FARMA NOORD Kalmthout€1.1m€0.1m
Apotheek Plaza Roeselare€0.9m€0.1m
Apotheek Sigrid Saelens Poperinge€1.1m€0.1m
PHARMACIE FANNY GARIN Mons€0.8m€0.1m
Van Geem Antwerpen€1.1m€0.1m
Full comparison

Key facts about CHARLOTTE THEUNISSEN

What is the company number of CHARLOTTE THEUNISSEN?
The company number of CHARLOTTE THEUNISSEN is 0847.201.166. The VAT number is the same number with BE in front: BE 0847.201.166.
Where is CHARLOTTE THEUNISSEN based?
The registered office is at Kiezelweg 428, 3620 Lanaken.Company details
What does CHARLOTTE THEUNISSEN do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of CHARLOTTE THEUNISSEN?
The legal form of CHARLOTTE THEUNISSEN is Private limited company (BV).
When was CHARLOTTE THEUNISSEN founded?
CHARLOTTE THEUNISSEN was founded on 06-07-2012.
Is CHARLOTTE THEUNISSEN still active?
Yes, CHARLOTTE THEUNISSEN is an active enterprise in the KBO register.
What is the turnover of CHARLOTTE THEUNISSEN?
The turnover in financial year 2025 is ≈ €560,000. This figure is estimated from the gross margin of €120,675 and 51 comparable companies (NACE 477). It probably lies between €380,000 and €1.1m.Financials
Is CHARLOTTE THEUNISSEN profitable?
In financial year 2025, CHARLOTTE THEUNISSEN made a profit of €77,355.
Where can I find the annual accounts of CHARLOTTE THEUNISSEN?
CHARLOTTE THEUNISSEN filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of CHARLOTTE THEUNISSEN due?
CHARLOTTE THEUNISSEN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.